1 drug 2hot flash 3sexual dysfunction Tamoxifen tamoxifen CLINICAL PRESENTATION AND EVALUATION ID: 931573
Download Presentation The PPT/PDF document "Gynecologic problems in Brest cancer" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Slide2Gynecologic problems in Brest cancer
Slide31. drug
2.hot flash.
3.sexual dysfunction
Slide4Tamoxifen:
Slide5tamoxifen:
Slide6Slide7CLINICAL PRESENTATION AND EVALUATION
Slide8AUB:
(ACOG) advised that women on
tamoxifen
should report any abnormal vaginal symptoms, including
bloody discharge, spotting, staining, or
leukorrhea
Slide9Slide10Post menopausal bleeding:
Slide11many
women
have
cervical stenosis
and office
biopsy
is not possible. In these patients, we manage expectantly if there is a thin endometrial echo
(≤4 mm).
Slide12Slide13Slide14PRE MENOPUASE:
Slide15Slide16Endometrial Polyp:
Slide17E
endometrial polyp:
Slide18Slide19Glandular Cystic Atrophic:
Slide20Endometrial Hyperplasia:
Slide21Endometrial cancer:
Slide22ACOG:
recommends against screening asymptomatic women on tamoxifen for EC
Slide23Uterine sarcoma and carcinosarconma
:
Slide24If sarcoma
is
suspected, the patient should undergo surgical
evaluation,
we have a low threshold for
hysterectomy
when a large
myometrial
or endometrial mass is identified in a symptomatic woman on
tamoxifen
.
Slide25Slide26Pregnancy and Brest cancer:
Slide27Slide28Sexual dysfunction:
Slide29Slide30Intrarosa
:
parstrone
vaginal
6.5 mg/daily
empty bladder
Slide31Hot flash:
HRT Not recommended
Slide32Slide33Slide34Slide35